By BOPA GAP on 5th April 2024

Published: BOPA Delphi consensus guidelines

The BOPA Guidelines, Advocacy And Publications Committee is pleased to announce that the British Oncology Pharmacy Association Delphi consensus guidelines is now published on the Journal of Oncology Pharmacy Practice.…

Read article
By BOPA GAP on 20th March 2024

Published: BOPA Guide to Producing a Position Statement

As an organisation BOPA represents the interests of its members and the wider oncology pharmacy workforce by developing and adopting position statements in response to changes in healthcare policy, or…

Read article
By BOPA Committee on 9th January 2024

Prescriber competencies for reviewing and prescribing SACT

The UK SACT Board is please to announce that the new guidance on Prescriber competencies for reviewing and prescribing SACT has been published. It is available from the Publications section on the…

Read article
By BOPA on 21st September 2023

The guidance on the use of oral SACT for patients unable to swallow has been released!

Administration of oral systemic anticancer therapy (SACT) via enteral feeding tubes and other methods (Version 2) This document replaces one in the Oral SACT Counselling Handbook for Pharmacy and Nursing…

Read article
By BOPA on 21st September 2023

General principles to support SACT aseptic capacity pressures

We are delighted to confirm that the UK SACT Board has now published General principles to support Systemic Anti-Cancer Therapy aseptic capacity pressures. It is available on the UKSB website.…

Read article
By BOPA on 20th September 2023

BOPA Education & Training Standards for Registered Pharmacy Professionals working in Cancer Services

BOPA are pleased to announce that the BOPA Education & Training Standards for Registered Pharmacy Professionals working in Cancer Services have been updated to incorporate the digital passport and level…

Read article
By BOPA on 19th September 2023

BOPA Standards for the Pharmacy Verification of Prescriptions for Cancer Medicines

Dear Members, A new version of the BOPA Standards for the Pharmacy Verification of Prescriptions for Cancer Medicines has been uploaded. https://www.bopa.org.uk/resources/bopa-standards-for-clinical-pharmacy-verification-of-cancer-medicine-prescriptions/ Change: They are now endorsed by the RPS.

Read article
By BOPA on 16th July 2023

Changing Services, Changing Oncology Pharmacy COVID-19 Position Statement – Update 2013

Our positions statement – Changing Services changing Oncology Pharmacy COVID-19 has been updated for 2013. To access the document you must be a free or paid member of BOPA. https://www.bopa.org.uk/resources/changing-services-changing-oncology-pharmacy-covid-19-position-statement/ 

Read article
By BOPA committee on 30th June 2023

Innovations in Oncology – More responsibility for cancer pharmacists and pharmacy technicians to improve care

We supported the Innovations in Oncology campaign that launched on 28th June within the Guardian and online at https://bit.ly/3CLngdR Innovations in Oncology looked at how new innovations are transforming the…

Read article
By BOPA Committee on 7th April 2023

TPMT/NUDT15 pharmacogenetic testing now commissioned

TPMT and NUDT15 pharmacogenetic testing is now commissioned on the NHS for both adult and paediatric patients with Acute Lymphoblastic Leukaemia only, the updated  national genomic test directory can be…

Read article
By BOPA on 2nd August 2022

Publication update – National SACT regimen specific consent form – Colorectal update

Dear All, The consent form project team is pleased to announce that the colorectal SACT consent forms have been reviewed and updated. They are available on the CRUK website at:…

Read article
By UK Chemo Board on 4th February 2022

PUBLISHED by UKCB: Standards for the safer use of ePMA systems for use in SACT Services

Please click here to see version 3.0 of the Standards for the safer use of ePMA systems for use in SACT Services. We would like to thank everyone involved in all…

Read article